4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-23-031389
Options or other derivatives
- Chief Medical Officer acquired 1,250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Arbet-Engels Christophe Chief Medical Officer | 2023-08-31 | Grant or award · Stock Option (right to buy) | +1,250,000 | $1.28 | $1,600,000 | 1,250,000 | D |
Loading xslF345X05/wk-form4_1693944923.xml…